These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32340799)

  • 1. Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective.
    Wong GL; Wen WH; Pan CQ
    Best Pract Res Clin Obstet Gynaecol; 2020 Oct; 68():54-65. PubMed ID: 32340799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
    Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
    Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
    Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
    J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of TAF, TDF, and LdT to prevent the transmission of hepatitis B in pregnant women: A retrospective study.
    Pan S; Zhang Y; Zeng Y; Lin C
    Immun Inflamm Dis; 2024 Feb; 12(2):e1204. PubMed ID: 38414328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
    Wang M; Ran R; Zhu Y; Zhang H
    Int J Gynaecol Obstet; 2023 Feb; 160(2):646-652. PubMed ID: 35816243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
    Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
    N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
    Janekrongtham C; Punsuwan N; Thitichai P; Lertpiriyasuwat C; Pan-Ngum W; Poovorawan K; Jantarapakde J; Tangkijvanich P
    BMJ Open; 2023 Jul; 13(7):e067275. PubMed ID: 37474179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Efficacy and Safety of Tenofovir Disoproxil Fumarate in Intercepting Mother-to-Child Transmission of Hepatitis B Virus.
    Han D; Du J; Wang W; Wang C
    Acta Med Okayama; 2024 Apr; 78(2):107-113. PubMed ID: 38688828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
    Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
    Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
    Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
    Samadi Kochaksaraei G; Shaheen AA; Seow CH; Barkema HW; Coffin CS
    Liver Int; 2022 Aug; 42(8):1712-1730. PubMed ID: 35312156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
    Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH
    Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.